| Literature DB >> 20922041 |
Ahmed M Emarah1, Shawky M El-Haggar, Ihab A Osman, Abdel Wahab S Khafagy.
Abstract
OBJECTIVES: Arteriogenic erectile dysfunction (ED) is a target organ disease of atherosclerosis, and therefore might be a predictor of systemic atherosclerosis. Being systemic, it might be possible to evaluate the extent of atherosclerosis from retinal vascular findings. We investigated the possible correlation between penile cavernosal artery blood flow and retinal vascular findings in patients with arteriogenic ED. PATIENTS AND METHODS: Sixty patients with ED were divided according to the peak systolic velocity (PSV) in their penile cavernosal arteries into two groups; Group A included 30 patients with PSV less than 25 cm/sec, and Group B included 30 patients with PSV more than 35 cm/sec. Blood flow in the penile cavernosal artery was measured with color Doppler ultrasonography. All patients were assessed by ocular fundus examination under amydriatic conditions to evaluate retinal vascular atherosclerotic changes using Hyman's classification.Entities:
Keywords: atherosclerosis; erectile dysfunction; retinal vascular atherosclerosis
Year: 2010 PMID: 20922041 PMCID: PMC2946996 DOI: 10.2147/opth.s11334
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Data of the studied groups (mean ± SD, range)
| Group A (n = 60) | 6.7 ± 1.82 (3–11) | 19.1 ± 3.39 (12.0–24.0) | 18.57 ± 3.88 (12.0–24.0) | 8.43 ± 5.1 (1–24) | 8.87 ± 5.55 (1.0–29.0) |
| Group B (n = 40) | 10.73 ± 2.84 | 48.57 ± 10.98 | 49.83 ± 11.37 | 3.77 ± 1.83 | 3.3 ± 2.1 |
| Group A (n = 22) | 6.36 ± 1.03 | 17.36 ± 1.29 | 15.82 ± 2.44 | 3.18 ± 1.78 | 2.18 ± 1.6 |
| Group B (n = 8) | 10.83 ± 4.31 | 38.67 ± 2.16 | 42.67 ± 6.53 | 5.67 ± 1.2 | 7.0 ± 2.37 |
| Group A (n = 38) | 6.89 ± 2.16 | 20.1 ± 3.83 | 20.16 ± 3.7 | 9.13 ± 5.4 | 9.33 ± 6.04 |
| Group B (n = 23) | 10.71 ± 2.48 | 51.04 ± 10.9 | 38.67 ± 11.7 | 4.11 ± 1.82 | 3.95 ± 2.1 |
| Group A (n = 28) | 6.86 ± 2.14 | 18.43 ± 2.56 | 17.64 ± 3.48 | 7.27 ± 3.07 | 7.82 ± 3.06 |
| Group B (n = 14) | 10.91 ± 2.17 | 45.45 ± 8.12 | 47.64 ± 10.72 | 3.29 ± 1.98 | 2.64 ± 2.2 |
| Group A (n = 23) | 6.56 ± 2.1 | 19.69 ± 3.2 | 19.38 ± 2.8 | 9.1 ± 5.9 | 9.47 ± 6.59 |
| Group B (n = 26) | 10.63 ± 3.22 | 50.37 ± 12.2 | 51.1 ± 11.8 | 4.19 ± 1.1 | 3.88 ± 1.4 |
| Group A | |||||
| Normal (n = 22) | 6.55 ± 2.02 | 22.73 ± 1.42 | 22.82 ± 1.33 | 4.0 ± 2.0 | 4.1 ± 2.1 |
| Affected (n = 38) | 6.79 ± 1.75 | 17.0 ± 2.2 | 16.1 ± 2.42 | 3.63 ± 1.74 | 2.8 ± 2.0 |
| Group B | |||||
| Normal (n = 28) | 11.2 ± 3.13 | 53.6 ± 10.1 | 54.8 ± 10.8 | 5.55 ± 1.6 | 6.0 ± 1.9 |
| Affected (n = 12) | 9.80 ± 1.93 | 38.5 ± 1.84 | 39.9 ± 2.4 | 9.9 ± 5.6 | 10.3 ± 6.2 |
Abbreviations: IIEF-5, score of the international index of erectile function questionnaire; PSV, peak systolic velocity; EDV, end diastolic velocity.
Statistically significant.